United States - English - NLM (National Library of Medicine)

natural health supply - lactose, x-ray exposed (1000 rad) (unii: lnt739i158) (lactose, x-ray exposed (1000 rad) - unii:lnt739i158) - lactose, x-ray exposed (1000 rad) 30 [hp_c] in 1 ml - indications: to be used for acute self-limiting conditions according to standard homeopathic indications purpose: fatigue

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - indapamide hemihydrate, quantity: 2.5 mg - tablet, sugar coated - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; purified talc; calcium carbonate; titanium dioxide; sucrose; acacia; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; shellac; white beeswax; carnauba wax - management of essential hypertension. it may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. normally indapamide is used as the initial agent in multiple drug regimens.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ranvet pty. limited - lactose - unknown - lactose carbohydrate active 0.0 - active constituent

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - lactose - not applicable - 1mg/1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m loveridge ltd - lactose - not applicable - 1mg/1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - lactose - not applicable - 1mg/1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - lactose - not applicable - 1mg/1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - lactose - oral solution - 200mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - lactose - oral solution - 125mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - everolimus, quantity: 1 mg - tablet, uncoated - excipient ingredients: butylated hydroxytoluene; lactose monohydrate; hypromellose; magnesium stearate; crospovidone; lactose - certican is indicated for the prophylaxis of organ rejection in adult patients at mild to moderate immunological risk receiving an allogeneic renal or cardiac transplant and in adult patients receiving an allogeneic hepatic transplant (see precautions).